[Oral antineoplastic agents for prostate cancer].
Department of Urology, The University of Tokyo Hospital.
Haruki
H
Kume
D000284:Administration, Oral; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D004338:Drug Combinations; D004961:Estramustine / Q000008:administration & dosage; D006801:Humans; D008297:Male; D010094:Oxonic Acid / Q000008:administration & dosage; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D005641:Tegafur / Q000008:administration & dosage; D014498:Uracil / Q000008:administration & dosage
D000970:Antineoplastic Agents; D018931:Antineoplastic Agents, Hormonal; D004338:Drug Combinations; C079198:S 1 (combination); D005641:Tegafur; D004961:Estramustine; D014498:Uracil; D010094:Oxonic Acid